Abstract:
The present disclosure relates to a system for and a method of incorporating SARS-CoV-2 genes and proteins into T4 phages. The present disclosure also relates to vaccine against SARS-CoV-2 containing recombinant T4 phages created using the method provided in the present disclosure.
Abstract:
Methods and materials are described for the removal of iodate from aqueous solutions. The methods comprise reduction of the iodate to iodide and subsequent or concurrent removal of the iodide by sorption, ion exchange, or precipitation. These methods are effective for the removal of radioactive iodine from radioactive and nuclear wastes.
Abstract:
Described is an "artificial virus" (AV) programmed with biomolecules that can enter human cells and carry out precise human genome modification. The AVs comprise: at least one viral vector, such as bacteriophage T4; at least one therapeutic molecule, such as DNA, RNA, protein and their complex; and a lipid coating. Also described is a method of human genome modification, using such an AV, and a method of program such an AV.
Abstract:
The present disclosure provides a geopolymer composition having a controllable setting time comprising: at least one reactive aluminosilicate; at least one retarder; and at least one alkali silicate activator solution.
Abstract:
The present invention describes a partial independent component (PICA) technique for blindly separating partially independent and/or gaussian-like sources from mixed observations over an informative index subspace, which allows various applications in independent component imaging. The present invention estimates a demixing matrix using only the independent and/or nongaussian portion of the observations. The present invention also demonstrates the principle of the approach on both controlled cases and real-world problems, and describes many extended applications of such a technique.
Abstract:
The disclosed embodiments of the inventions disclosed in this application develop a "protection" electric, magnetic or electromagnetic field or fields which are either superimposed upon an ambient field which is detrimental to the health of living systems, or is incorporated into the electrical circuit of the device which is generating the detrimental field. Either arrangement is successful in "confusing" living cells, and thereby reducing the harmful effects of the otherwise detrimental field.
Abstract:
Described is an engineered viral particle programmed with T cell targeting specificity. The viral particles comprise: at least one viral vector, such as bacteriophage T4; and at least one CD4-binding protein displayed on the surface of the viral vector. Also described is a method of reactivate latent HIV-1 and cure patient with HIV-1 infection, using such an engineered viral particle.
Abstract:
A high performance concrete composition comprising: (i) at least one Class C fly ash, (ii) at least one calcium aluminate cement, (iii) at least one aggregate, and (iv) water.
Abstract:
Provided herein are HIV vaccines that encompasses recombinant trimers that mimic native HIV-1 envelope trimers. Also provided are methods of administering to a subject in need thereof an HIV vaccine provided herein to elicit antibodies against a recombinant trimer in the subject. A recombinant trimer is formed by a recombinant protein comprising a recombinant HIV-1 gp140 fused to a tag through a linker at C-terminus of the recombinant HIV-1 gp140, wherein the linker is sufficiently long so that the tag is accessible for binding by a binding molecule bound on a solid matrix during purification of the recombinant trimer.
Abstract:
An approach of producing recombinant trimers that mimic native HIV-1 envelope trimers is developed. A recombinant protein forming the recombinant trimers encompasses a recombinant HIV-1 gpl40 fused to a tag through a linker at C-terminus of the recombinant HIV-1 gpl40. The linker is sufficiently long so that the tag is accessible for binding by a binding molecule bound on a solid matrix. After expressed in a cell, the recombinant protein is secreted into the culture medium and assembles into recombinant trimers therein. The recombinant trimers may be directly purified from the culture medium. Cleaved and uncleaved trimers from different clade viruses are produced.